


Dr. Sofia Merajver, MD
Dr. Sofia Merajver, MD is a medical oncologist in Ann Arbor, MI and has over 35 years of experience in the medical field. She graduated from University of Michigan Medical School in 1987. She is affiliated with University Hospital-University of Michigan. She is accepting telehealth appointments.
Practice
1500 E Medical Center Dr Ann Arbor, MI 48109Make an Appointment
Hospital Highlight
Dr. Merajver is affiliated with University Hospital-University of Michigan Ann Arbor, a highly rated hospital.
At a Glance
- Area of Expertise
- Friendly Staff
- Offers TelehealthThis doctor offers telehealth appointments. Call the office to schedule an appointment.
- Practices at Top Hospital

Save money with free prescription discounts
Experience Check
Search for experience in a specific area
Insurance Check
Search for your insurance carrier and choose your plan type
Dr. Merajver's Reviews
Likelihood to recommend Dr. Merajver
4.0
5 Star | 75% | 75% |
4 Star | 0% | 0% |
3 Star | 0% | 0% |
2 Star | 0% | 0% |
1 Star | 25% | 25% |
Leave a review
How was your experience with Dr. Merajver?Overall Patient Satisfaction
Likelihood of recommending Dr. Merajver to family and friends is 4 out of 5
About Me
biography
Dr. Sofia Merajver, MD is a medical oncologist in Ann Arbor, MI and has over 35 years of experience in the medical field. She graduated from University of Michigan Medical School in 1987. She is affiliated with University Hospital-University of Michigan. She is accepting telehealth appointments.Medical Oncology
*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.
University Of Michigan Hospitals
Fellowship Hospital, 1993University Of Michigan Hospitals
Residency Hospital, 1991University Of Michigan Hospitals
Internship Hospital, 1989University Of Michigan Medical School
Medical School, 1987
Healthgrades receives board action history for physicians and physician assistants. The information displayed here is sourced from independent information providers, such as state board websites, and may not be the most up-to-date information. Healthgrades makes no representations with respect to the accuracy of any information provided here and assumes no responsibility or liability for such information.
Learn more about medical license public record checkDevelopment of an Enhanced-Throughput Radial Cell Migration Device, 2020-11-12
MEK is a promising target in the basal subtype of bladder cancer, 2020-11-03
Norstictic Acid Is a Selective Allosteric Transcriptional Regulator, 2021-06-17
Optimizing Precision Medicine for Breast Cancer Brain Metastases with Functional Drug Response Assessment, 2023-06-21
Reliability of medical records in diagnosing inflammatory breast cancer in Egypt, 2017-03-16
RhoC Expression and Head and Neck Cancer Metastasis, 2009-10-27
RhoC Impacts the Metastatic Potential and Abundance of Breast Cancer Stem Cells, 2012-07-23
Risk Factors for Chronic Mastitis in Morocco and Egypt, 2013-11-14
Public and Professional Educational Needs for Downstaging Breast Cancer in Egypt, 2014-12-17
Shock wave impact on the viability of MDA-MB-231 cells, 2020-06-04
Heterogeneity at the invasion front of triple negative breast cancer cells, 2020-04-01
Retroactive Signaling in Short Signaling Pathways, 2012-07-26
Promoters of and barriers to cervical cancer screening in a rural setting in Tanzania, 2013-09-04
Risk Factors for Inflammatory and non-Inflammatory Breast Cancer in North Africa, 2020-09-02
Load-Induced Modulation of Signal Transduction Networks, 2011-10-11
Clinical and Epidemiologic Profile of Breast Cancer in Tanzania, 2014-12-17
Satisfaction with Clinician-Led Germline Genetic Counseling in Men with Prostate Cancer, 2022-08-05
Impact of between-tissue differences on pan-cancer predictions of drug sensitivity, 2021-02-25
Tracking the tumor invasion front using long-term fluidic tumoroid culture, 2017-09-07
A Hidden Feedback in Signaling Cascades Is Revealed, 2008-03-21
Clinical Predictors of Long-term Survival in HER2-positive Metastatic Breast Cancer, 2016-02-13
Cancer classification in the genomic era: five contemporary problems, 2015-10-19
Focus on Breast Cancer
Locations
Practice
Practice
Affiliated Hospitals
- Recipient of 15
hospital awardsView all awardsOutstanding Patient Experience Award™ (2024, 2023, 2022)
Top in the nation for overall patient experience based on nine measures related to doctor and nurse communication, hospital cleanliness and noise levels, and medication and post-discharge care instructions
View all patient feedbackHow patients felt about the care they received at this hospital.
89%Patients said they were given information about recovering at home5% higher than the national average
83%Patients would recommend the hospital to friends and family18% higher than the national average
Compare Providers
Providers shown based on Dr. Merajver's location and specialty. Show more Oncologists.
Your trust is our top concern. Learn more.
We monitor all reviews to ensure they comply with our guidelines and don’t include personal information, profanity, libel, defamation, harassment, obscenity or fraud.
All reviews are confirmed and audited before publication, and community members have the ability to flag inappropriate content for further review by our team.
Doctors can not pay for good reviews, nor can they pay to have negative reviews removed.
Any reviews that are deemed fraudulent or violate our guidelines will be removed immediately.